Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001628280-22-016875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-10 | 2022-06-08 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | P - Purchase | $0.96 | +45.9K | 882.9K | +5% | +$44.0K |
| D | 2022-06-10 | 2022-06-08 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | P - Purchase | $0.13 | +45.9K | 45.9K | New | +$5,963 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | P | A | 45,871 | $0.96 | 882,871 | D | — | — | (F1) Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13. |
| 2 | Derivative | Warrant (Right to Buy) | 2022-06-08 | P | A | 45,871 | $0.13 | 45,871 | D | $0.96 · 2022-12-08 to 2027-06-08 | 45,871 Common Stock | (F1) Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13. |